Is temsirolimus FDA approved?

FDA Approves Temsirolimus for the Treatment of Advanced Kidney Cancer. Wyeth Pharmaceuticals recently announced that the US Food and Drug Administration (FDA) has approved temsirolimus (Torisel) for patients with advanced renal cell carcinoma (RCC).

Is torisel chemotherapy?

Torisel is the trade name for the generic chemotherapy drug Temsirolimus . In some cases, health care professionals may use the generic name Temsirolimus when referring to the trade drug name Torisel. Drug Type: Torisel is a targeted therapy. It is classified as a mTOR inhibitor.

What is Temsirolimus used for?

Temsirolimus is used to treat advanced renal cell carcinoma (RCC, a type of cancer that begins in the kidney). Temsirolimus is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that tells the cancer cells to multiply. This may help slow the growth of tumors.

What drugs are MTOR inhibitors?

List of MTOR inhibitors:

Drug Name Avg. Rating Reviews
Afinitor (Pro) Generic name: everolimus 5.6 19 reviews
Torisel (Pro) Generic name: temsirolimus 9.5 2 reviews
Zortress (Pro) Generic name: everolimus 10 1 review
Rapamune (Pro) Generic name: sirolimus 10 No reviews

What kind of cancer is temsirolimus used for?

Temsirolimus is used to treat advanced renal cell carcinoma (RCC, a type of cancer that begins in the kidney). Temsirolimus is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that tells the cancer cells to multiply.

Are there any side effects to taking temsirolimus?

Grapefruit and grapefruit juice may interact with temsirolimus and lead to unwanted side effects. Avoid the use of grapefruit products while taking Torisel. This medicine can pass into body fluids (urine, feces, vomit). For at least 48 hours after you receive a dose,…

What is the mechanism of action of temsirolimus?

Temsirolimus is a Kinase Inhibitor. The mechanism of action of temsirolimus is as a Protein Kinase Inhibitor.

How much Temsirolimus is in a 3 ml vial?

Inject 1.8 mL of supplied diluent to the vial (25 mg/mL). Drug vial contains an overfill of 0.2 mL (30 mg/1.2 mL). So final drug concentration=10 mg/mL for a total volume of 3 mL Solution should be clear to slightly turbid, colorless to yellow, and free from visual particulates